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Abstract 
Several studies suggest that synergisms between Mycoplasma bovis and other microorganisms might exacerbate 
disease outcome of bovine mycoplasmosis. Screening several bovine cell types to assess their potential use as in vitro 
infection models for M. bovis, it was observed that a widely used cell line of bovine macrophages (Bomac cells) is 
in fact persistently infected with bovine viral diarrhea virus (BVDV). The cell line was first cured of this virus allowing 
comparative studies between both cell lines. Subsequently, uptake and co-culture of two M. bovis strains of different 
clonal complexes with Bomac cells contaminated with BVDV and in BVDV-free Bomac cells were assessed. Addition-
ally, cell viability, cytotoxicity and induction of apoptosis after infection with M. bovis were evaluated. No differences 
in the levels of uptake and growth in co-culture were observed between the two Bomac cell types and both M. bovis 
strains. Cytotoxicity was increased after infection of BVDV-free cells with one of the two strains, while apoptotic cell 
death was slightly induced by this strain in both cell lines. Overall, the presence or absence of BVDV in Bomac cells 
did not grossly change the parameters tested upon infection with M. bovis. Nevertheless, this cell model is very useful 
when studying viral co-infections with bacteria and could also be used for multiple co-infections. Considering the 
broad contamination of cell cultures with BVDV, careful screening for this virus should routinely be performed as its 
presence might be relevant depending on the molecular mechanisms being investigated.
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and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Mycoplasma bovis is one of the major causative agents 
of bovine mycoplasmosis [1]. This disease has a broad 
range of clinical manifestations including pneumonia, 
mastitis, polyarthritis, otitis media and genital disorders 
in cattle [2–5]. In  vivo antibiotic treatments are ineffi-
cient and no effective commercial vaccine is available 
[6]. Although this bacterium was first isolated in 1961 
[7], the molecular mechanisms involved in the patho-
genesis of bovine mycoplasmosis due to M. bovis are 
still poorly understood. Several studies suggest a multi-
factorial origin for disease development [1]. Thus, vari-
able surface lipoproteins [8–13], adhesion and uptake 
by host cells [14–20], modulation of the host’s immune 
system [21–26], biofilm formation [27], synergistic 
interactions with other bacterial or viral pathogens 
[28–31] and the release of secondary metabolites [32, 
33] were investigated. An interesting aspect observed in 
previous experimental studies and by analyzing material 
collected from natural infections is the synergistic inter-
action of M. bovis with other bacterial or viral patho-
gens in the development of severe lesions [28, 29]. The 
main microorganisms suspected to play a role in this 
process are Pasteurella multocida, Mannheimia haemo-
lytica, Histophilus somni, bovine respiratory syncytial 
virus (BRSV), bovine herpes virus 1 (BHV-1), bovine 
viral diarrhea virus (BVDV) and parainfluenza virus 
type 3 (PIV-3), although some studies showed contra-
dictory findings [1, 31, 34]. For this reason, in vivo and 
in vitro experimental data focusing on co-infections and 
host response are necessary to dissect the mechanisms 
involved in these potential synergistic interactions. 
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Intracellular localization of M. bovis in host cells, 
including macrophages, was previously shown in  vivo, 
but in  vitro data were missing until recently [18–20, 
35]. Lately, two research groups demonstrated in  vitro 
uptake of M. bovis by several primary bovine cell types, 
including peripheral blood mononuclear cells (PBMCs), 
erythrocytes and turbinate cells [21, 36, 37]. How-
ever, the drastic cytotoxic effect of M. bovis on bovine 
endothelial cells, PBMCs and alveolar macrophages was 
not observed [37, 38]. Moreover, the induction of apop-
tosis following cell infection with M. bovis has been 
rarely studied, with inconsistent results observed with 
PBMCs and epithelial cells [21, 23, 39], and even a delay 
in apoptosis with bovine peripheral monocytes [22]. In 
addition, the synergistic effects of co-infections on cell 
uptake of M. bovis, cytotoxicity towards cells and induc-
tion of apoptosis have not been studied in vitro to date. 
Thus, the gathering of experimental data while testing 
standardized cell models is fundamental when investi-
gating these topics in more detail and to understand the 
mechanisms involved. Accordingly, in  vitro cell mod-
els are indispensable when dissecting the molecular 
and cellular details of biological processes occurring in 
specific cell types [40]. A point to ponder is the choice 
between primary cells and/or cell lines. Both systems 
are useful and have advantages and drawbacks [41]. Pri-
mary cells mimic the in  vivo situation better than cell 
lines but primary cells originate from several individual 
animals and are thus prone to exhibit high variability 
between experiments and between different laborato-
ries. Additionally, the isolation of primary cells is time 
consuming and these cells are in general less character-
ized. On the other hand, cell lines are “immortalized” 
and are in general well-characterized, very convenient 
to work with, show less variation between experiments 
and, importantly, are amenable to genetic engineering 
[42], which makes them first choice for initial studies 
aiming to characterize specific cell features.
In the present study, a bovine macrophage (Bomac) 
cell line, developed from bovine peritoneal mac-
rophages by Stabel and Stabel in 1995 [43], was tested 
as an infection model for M. bovis to further investigate 
cellular mechanisms involved in mycoplasma–Bomac 
cell interaction. This cell line is widely used in research 
but proved to be contaminated with BVDV. The cell 
line was cured of the virus, and both BVDV-infected 
and BVDV-free Bomac cells were tested for mycoplas-
mal uptake, growth in co-culture, viability, cytotoxic-
ity and induction of apoptosis after infection with M. 
bovis. The aim of this study was to compare the param-
eters mentioned above in both BVDV-infected and 
BVDV-free Bomac cells.
Materials and methods
Bacterial strains and axenic growth conditions
Mycoplasma bovis strain JF4278, isolated from the milk 
of a cow with mastitis and pneumonia in Switzerland in 
2008 [44] and M. bovis strain L22/93, isolated from the 
lung of a cow in Switzerland in 1993, were filter-cloned 
and used for the experiments. These two strains were 
chosen as representative strains of the two distinct clonal 
complexes (CC) isolated in Switzerland. Strain JF4278, 
which belongs to the currently circulating clonal complex 
CC1, is associated with an increase of reported cases of 
severe mastitis. Strain L22/93 belongs to CC5 and was 
circulating in Switzerland until around 2007 [45]. The 
strains were pre-cultured for 20 h in SP4 broth medium 
[46] supplemented with 50  μg/mL cefoxitin sodium salt 
(Sigma-Aldrich, Buchs, Switzerland) or for 4–5  days on 
agar plates at 37 °C in a humidified atmosphere. The con-
centration of mycoplasmas of all liquid pre-cultures was 
measured by performing 10-fold serial dilutions and plat-
ing on SP4 agar plates. A growth curve of both strains in 
SP4 broth medium was performed. Ten microliter of the 
mycoplasmas frozen stock was added to 990  μL of SP4 
broth medium and incubated for 20  h to have approxi-
mately 6 × 108 cells/mL (strain JF4278) or 1 × 108 CFU/
mL (strain L22/93). 10-fold serial dilutions were further 
performed in a volume of 2 mL SP4 broth medium and 
all dilutions were plated on SP4 agar plates to confirm 
the concentration of mycoplasmas of the pre-culture. 
To measure growth curves starting with approximately 
100  CFU/mL, the dilution  10−7 (strain JF4278) and the 
dilution  10−6 (strain L22/93) were used as starting cul-
tures (time point 0). One hundred μL of the culture were 
taken at time points (hours): 0, 6, 24, 30, 48, 54 and 72. 
Ten microliter of 10-fold serial dilutions were plated on 
SP4 agar plates and incubated. Subsequently, colonies 
were counted under a stereomicroscope. The assay was 
performed in three independent experiments.
Bacterial generation time in axenic medium
The generation time of both strains of M. bovis during the 
exponential phase was calculated using the data obtained 
for axenic growth with the following formula [47]:
G represents the generation time in hours, t the inter-
val of time and n the number of generations. The num-
ber of generation n is first determined with the formula 
described below:
G =
t
n
n =
log (a)− log(A)
log(2)
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a represents the number of bacteria at the end of the time 
interval, while A is the number of bacteria at the begin-
ning of a time interval. A is the number of bacteria at 
time point 6 h and a is the number of bacteria at 30 h.
Bovine macrophage (Bomac) cell lines
Bomac cells [43, 48] were maintained at 37 °C in a humid-
ified 5%  CO2 atmosphere in minimal essential medium 
(MEM)-Earle medium supplemented with 2.2  g/L 
 NaHCO3 (Biochrom, Berlin, Germany), 1% l-glutamine 
(Biochrom), 7% fetal calf serum (Gibco Life Technolo-
gies, Rockville, USA) and 1  × penicillin–streptomycin 
mixture (Gibco). Cells were routinely screened to ensure 
the absence of contamination with mycoplasmas using 
PCR with the  Venor®GeM kit (Minerva Biolabs, Berlin, 
Germany) and BVDV using immunostaining with an in-
house swine anti-BVDV hyperimmune serum (National 
Reference Center for BVDV, Institute of Virology and 
Immunology) as previously described [36]. The origi-
nal Bomac cell line present in the laboratory [48] was 
found to be positive for BVDV. Subtyping of the virus 
[49] revealed the presence of BVDV genotype-2. The cell 
line was subsequently cured of the BVDV by several pas-
sages in the presence of the aromatic cationic compound 
DB772 [50], a known inhibitor of pestivirus replication 
(Marti and Schweizer, manuscript in preparation). This 
second cell line, i.e., Bomac cured of BVDV, was main-
tained and grown for experiments using the same condi-
tions as the cell line infected with BVDV. Approximately 
4  ×  104 bovine cells were seeded per well containing 
0.5 mL of medium in 24-well plates  (TPP®) for cell infec-
tions and gentamicin protection assay and 8 × 103 bovine 
cells per well containing 100 μL in 96-well plates (Greiner 
Bio-One, Frickenhausen, Germany) for the ApoTox-Glo™ 
Triplex Assay in MEM-Earle without antibiotics 1  day 
before the experiments. The lowest passage used was 
23 for Bomac cells free of BVDV and 31 for Bomac cells 
infected with BVDV. The cells were used for the following 
10–40 passages until the end of the experiment without 
detection of overt changes during passaging.
Cell infection and gentamicin protection assay
The cell infection and gentamicin assays were adapted 
from a previous study using primary embryonic calf 
turbinate (PECT) cells [36]. The two strains of M. bovis 
were grown for 20 h as described above, then 1.5 mL of 
the pre-cultures were centrifuged 15  min at 5900  ×  g 
and washed once in PBS at pH 7.5. Mycoplasmas were 
further suspended and diluted in MEM-Earle medium 
to infect Bomac cells at a multiplicity of infection (MOI) 
ranging between 2 and 10 (Additional file  1). The MOI 
is defined as the number of added bacteria per indi-
vidual host cell. The plate was centrifuged for 5  min at 
600 × g to synchronize infection. After 3 h of infection, 
cells were washed twice with PBS followed by the addi-
tion of fresh MEM-Earle medium (cell infection assay) 
or MEM-Earle medium supplemented with 400  μg/mL 
gentamicin sulfate (TOKU-E Company, Bellington, USA) 
(gentamicin protection assay). Plates were incubated for 
3 additional hours (total of 6 h post-infection). Cells were 
subsequently washed three times with PBS to remove 
gentamicin and fresh MEM-Earle medium was added to 
each well. To evaluate uptake of mycoplasmas and sur-
vival, sampling was performed at three time points, i.e., 
at 0, 6 and 54 h post-infection. For the collection of sam-
ples at all time points, wells were washed with PBS and 
bovine cells were scraped and lysed mechanically using 
a 23-gauge needle and a syringe. Samples were taken to 
determine the CFU/well by performing 10-fold serial 
dilutions in PBS and plating the mycoplasmas on SP4 
agar plates. As controls, assays were performed with the 
two M. bovis strains without Bomac cells to ensure effi-
cient killing of extracellular mycoplasmas by gentamicin 
and were performed for each experiment with each cell 
line. These controls were performed in Eppendorf tubes 
and before washings; bacteria were centrifuged for 
15 min at 5900 × g. Additionally, the survival of M. bovis 
strains JF4278 and L22/93 in MEM-Earle medium and in 
MEM-Earle preincubated with both Bomac cell lines cells 
for 24 or 48 h was assessed as previously described [36]. 
The assays were performed in triplicates in three inde-
pendent experiments.
ApoTox‑Glo™ Triplex Assay
The ApoTox-Glo™ Triplex Assay (Promega, Madison, 
USA) assesses viability and cytotoxicity by a combination 
of cell-permeant and non-permeant protease substrates, 
detecting changes in cell membrane integrity and cas-
pase-3/7 activation, a hallmark for apoptosis induction. 
Briefly, cell viability is measured using a cell permeant 
substrate of a host protease that is inactivated when 
released in the cell culture medium. Cytotoxicity is quan-
tified by the cleavage of a substrate that is unable to pass 
through membranes but is cleaved when the protease 
is released in the cell culture medium. For apoptosis, 
a luminogenic substrate, is cleaved by activated cas-
pase-3/7. Preliminary tests were performed to evaluate 
the induction of apoptosis in Bomac cells after treatment 
with staurosporine (Abcam plc, Cambridge, UK). Stauro-
sporine was tested at final concentrations of 0, 0.5, 2.5, 
5 and 15 µM in MEM-Earle medium (Additional file 2). 
Twenty-four hours prior to the experiment, Bomac cells 
were seeded in black 96-well plates with a clear bot-
tom (Greiner Bio-One). Subsequently, cell medium was 
replaced with fresh medium. For the staurosporine tests, 
the different concentrations of staurosporine were added 
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to the cells 18 h after the addition of fresh medium and 
were incubated for an extra 6  h before performing the 
measurements. The ApoTox-Glo™ Triplex Assay was 
performed according to the manufacturer’s protocol. 
Fluorescence and luminescence signals were read with 
a Cytation 5 Cell Imaging Multi-Mode Reader (BioTek 
Instruments GmbH, Luzern, Switzerland) with the filter 
settings suggested in the ApoTox-Glo™ Triplex Assay 
protocol. For subsequent experiments, 2.5  µM stauro-
sporine was chosen since this concentration represents 
the beginning of the plateau of apoptosis induction in 
both cell lines used in this study.
To perform the ApoTox-Glo™ Triplex Assay with 
mycoplasmas, Bomac cells were seeded as described 
above. The cell medium was changed 24 h after cell seed-
ing, and Bomac cells were infected with M. bovis strains 
JF4278 and L22/93 at an MOI of approximately 5. At 
18 h post-infection, 2.5 µM staurosporine was added to 
selected samples for an additional 6  h. After a total of 
24 h of infection with M. bovis the ApoTox-Glo™ Triplex 
Assay was performed according to the manufacturer’s 
protocol. Fluorescence and luminescence signals were 
read with a Cytation 5 Cell Imaging Multi-Mode Reader 
as described above. All experiments were performed 
three times in duplicates.
Statistical analysis
Mycoplasma bovis titers (log(10) [CFU/well]) measured 
during infection assays are shown as means ± stand-
ard deviations of mean values from three independent 
experiments. The significance of differences between 
individual groups and strains in the same group in the 
gentamicin assay was calculated with the Welch’s t-test. 
For the ApoTox-Glo™ Triplex Assay, fluorescence- and 
luminescence-units for viability, cytotoxicity and apopto-
sis signals were displayed as relative values to uninfected 
cells. The significance of differences between uninfected 
and infected cells with either strain was calculated with 
the Welch’s t-test. Statistical analysis was performed 
using the software GraphPad Instat™ V2.05 (GraphPad 
Software Inc., La Jolla, CA, USA).
Results
M. bovis strain JF4278 reaches higher concentrations 
in SP4 medium and has a lower generation time than strain 
L22/93
The growth of M. bovis strains JF4278 and L22/93 in 
axenic medium (SP4) was measured. As shown in Fig-
ure 1, strain JF4278 reaches a concentration of one log10 
more than strain L22/93 in SP4 medium before attain-
ing the plateau of stationary phase. Additionally, after 
54 h of growth, the strain L22/93 enters the death phase 
(Figure 1). The generation time of both M. bovis strains 
in axenic medium (SP4) was calculated. The generation 
time of strain L22/93 was higher compared to JF4278. 
JF4278 had a generation time of 1.52  h  ±  0.08, while 
L22/93 had a generation time of 2.01 h ± 0.16.
M. bovis is internalized and grows in co‑culture 
with BVDV‑infected and cured Bomac cell lines
In order to evaluate mycoplasmas uptake and growth in 
co-culture of M. bovis with Bomac cells, cell infections 
and gentamicin protection assays were performed with 
Bomac cells as previously described for PECT cells [36]. 
For each experiment, controls including M. bovis in cell 
culture medium without addition of gentamicin with and 
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Figure 1 Growth curves of M. bovis in axenic medium. The straight line represents strain JF4278, while the dashed line represents strain 
L22/93. The x-axis indicates the timepoints and the y-axis the log10 CFU/mL. The data shown are the mean values of three independent experi-
ments. Standard deviations of individual measurements per time point are indicated as vertical bars.
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without Bomac cells were included. The incapacity of M. 
bovis to multiply in MEM-Earle medium was confirmed 
(Additional files 3 and 4). However, growth in spent 
MEM-Earle medium, from both cell lines, was observed 
(Additional files 3 and 4). Six hours post-infection with-
out gentamicin treatment and in co-culture with both 
cell lines, no significant differences between both M. 
bovis strains were noticed apart from a faint decrease 
in recovered L22/93 when co-infected with BVDV (Fig-
ure 2). Furthermore, a limited number of M. bovis cells 
were persisting in the cell medium when Bomac cells 
were not present. Fifty-four hours post-infection, fewer 
bacteria of the strain L22/93 were recovered in BVDV-
infected than in BVDV-free Bomac cells, whereas the 
difference for the strain JF4278 was not significant (Fig-
ure 2). No more viable bacteria were detected 54 h after 
the inoculation of M. bovis in medium without eukary-
otic cells (Figure 2). After the gentamicin treatment (6 h 
post-infection), no viable mycoplasmas were detected 
without co-cultivation with Bomac cells (Figure 3). After 
6 h of co-cultivation with Bomac cells, no significant dif-
ferences in the number of viable bacteria were observed 
between the two strains tested and between Bomac cells 
infected with BVDV and Bomac cells free of BVDV 
(Figure  3). At 54  h post-infection, a slight decrease in 
the number of viable L22/93 compared to JF4278 and a 
small reduction of each strain in BVDV-infected versus 
non-infected cells was noticed but without statistical 
significance (Figure 3).
M. bovis strain JF4278 induces slight cytotoxicity 
and apoptosis
In order to assess viability, cytotoxicity and induction of 
apoptosis in both Bomac cell lines, the ApoTox-Glo™ Tri-
plex Assay was used. Cell viability was evaluated for both 
cell lines with or without infection with both strains of 
M. bovis. These Bomac cells were treated chemically with 
staurosporine or left untreated. No significant decrease 
in cell viability was observed after infection with strains 
L22/93 and JF4278 in both cell lines (Figure 4; untreated). 
As expected, staurosporine severely decreased cell viabil-
ity in both cell lines (P-values: Bomac: 0.0001; Bomac 
with BVDV: 0.0031) (Figure 4; staurosporine). The cyto-
toxicity measurements showed a higher variability than 
the viability ones. Generally, infection with M. bovis 
seems to slightly decrease the measured cytotoxicity (Fig-
ure  5; untreated). However, the opposite is true in the 
case of strain JF4278 in Bomac cells free of BVDV (Fig-
ure  5: untreated). The cytotoxic effect measured after 
infection with the strain JF4278 in cells free of BVDV was 
confirmed by the ratio cytotoxicity-viability relative to 
M. bovis uninfected cells (Additional file 5). This was not 
observed in the case of Bomac cells infected with BVDV, 
although it has to be mentioned that for the untreated cell 
line, large variations were noted among the three differ-
ent experiments. Treatment with staurosporine induced 
cytotoxicity in Bomac cells free of BVDV compared to 
untreated cells (P-value 0.0005). In Bomac cells infected 
with BVDV, an increase in cytotoxicity was not observed 
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Figure 2 Infection model of M. bovis in Bomac cells. Time points 0, 6 and 54 h post-infection with an MOI between 2 and 10 are shown. 
Black columns correspond to strain JF4278 (co-culture), while grey columns correspond to strain L22/93 (co-culture). Vertically striped columns 
correspond to strain JF4278 alone in cell medium, while horizontally striped columns correspond to strain L22/93 alone in cell medium. The x-axis 
represents the number of hours post-infection (Bomac: Bomac cells free of BVDV; Bomac + BVDV: Bomac infected with BVDV), while y-axis repre-
sents the log10 CFU/well. The data shown are the mean values of triplicates of three independent experiments. Standard deviations of individual 
measurements are indicated as vertical bars. *P < 0.05, **P < 0.01, ***P < 0.001.
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after treatment with staurosporine (P-value 0.1149), 
probably due to high variability in cytotoxicity measure-
ments in untreated cells (Figure 5; staurosporine). Inter-
estingly, there is a statistically significant reduction of 
cytotoxicity in Bomac cells free of BVDV after treatment 
with staurosporine and infection with M. bovis (Figure 5; 
staurosporine). Staurosporine strongly induced apop-
tosis in both Bomac cell lines (P-values: Bomac: 0.0065; 
Bomac with BVDV: <  0.0001) (Figure  6; staurosporine) 
and the values are confirmed by the ratios measuring 
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Figure 3 Gentamicin protection assay. Time points 0, 6 and 54 h post-infection with an MOI between 2 and 10 are shown. Gentamicin was 
added 3 h post-infection and time 6 h post-infection corresponds to the end of the gentamicin treatment. Black columns correspond to strain 
JF4278 (co-culture), while grey columns correspond to strain L22/93 (co-culture). Vertically striped columns correspond to strain JF4278 alone in 
growth medium, while horizontally striped columns correspond to strain L22/93 alone in growth medium. The x-axis represents the number of 
hours post-infection (Bomac: Bomac cells free of BVDV; Bomac + BVDV: Bomac infected with BVDV), while y-axis represents the log10 CFU/well. The 
data shown are the mean values of triplicates of three independent experiments. Standard deviations of individual measurements are indicated as 
bars. *P < 0.05, **P < 0.01, ***P < 0.001.
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Figure 4 Viability assay. Time point 24 h post-infection with an MOI of approximately 5 is shown. Black columns correspond to uninfected cells, 
dark grey columns correspond to strain JF4278 (co-culture), while light grey columns correspond to strain L22/93 (co-culture). The data shown are 
the mean values of duplicates of three independent experiments. The x-axis represents the conditions tested (Bomac: Bomac cells free of BVDV; 
Bomac + BVDV: Bomac infected with BVDV), while y-axis represents the values of the measured test relative to untreated and uninfected cells. The 
values obtained for Bomac cell lines infected with M. bovis were normalized to values of the corresponding uninfected and untreated cells of each 
cell line. Standard deviations of individual measurements are indicated as bars. *P < 0.05, **P < 0.01, ***P < 0.001.
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apoptosis–viability relative to uninfected cells (Addi-
tional file  6). Cell infection with M. bovis strain JF4278 
slightly induced apoptosis (Figure 6; untreated). This was 
also observed after induction of apoptosis with stauro-
sporine but without statistical significance (Figure 6).
Discussion
Observations performed on necropsy material suggested 
a potential intracellular stage of M. bovis [18–20, 35]. 
Recently, in  vitro studies confirmed cell uptake of M. 
bovis and subsequent intracellular localization [21, 36, 
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Figure 5 Cytotoxicity assay. Time point 24 h post-infection with an MOI of approximately 5 is shown. Black columns correspond to uninfected 
cells, dark grey columns correspond to strain JF4278 (co-culture), while light grey columns correspond to strain L22/93 (co-culture). The data shown 
are the mean values of duplicates of three independent experiments. The x-axis represents the conditions tested (Bomac: Bomac cells free of BVDV; 
Bomac + BVDV: Bomac infected with BVDV), while y-axis represents the values of the measured test relative to untreated and uninfected cells. The 
values obtained for both Bomac cell lines infected with M. bovis were normalized to values of the corresponding uninfected and untreated cells of 
each cell line. Standard deviations of individual measurements are indicated as bars. *P < 0.05, **P < 0.01, ***P < 0.001.
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Figure 6 Apoptosis assay. Time point 24 h post-infection with an MOI of approximately 5 is shown. Black columns correspond to uninfected 
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Bomac + BVDV: Bomac infected with BVDV), while y-axis represents the values of the measured test relative to untreated and uninfected cells. The 
values obtained for both Bomac cell lines infected with M. bovis were normalized to values of the corresponding uninfected and untreated cells of 
each cell line. Standard deviations of individual measurements are indicated as bars. *P < 0.05, **P < 0.01, ***P < 0.001. In order to show the statistical 
differences observed for untreated cells, two graphs using different scales in the y-axis were merged.
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37]. These studies were mainly carried out in primary 
bovine cells. Although primary cells have the advantage 
of being closer to the in vivo situation, cell lines are more 
convenient to work with, generally display less variabil-
ity, and are amenable to genetic engineering. This is an 
obvious asset when dissecting the molecular and cellular 
mechanisms involved in host-M. bovis interactions that 
are not dependent on the variability of individual hosts 
[51]. Therefore, we chose a widely used bovine mac-
rophage cell line (Bomac cells) for further studies. The 
model was kept as simple as possible. Opsonins or other 
serum components were not added and, thus, this model 
does not reflect the role of macrophages in vivo. Interest-
ingly, the routine screening performed in our department 
to detect BVDV in cell cultures revealed a positive result 
for the Bomac cell line available in the laboratory. By 
curing the Bomac cell line of the contaminating BVDV 
type-2 (Marti and Schweizer, manuscript in preparation), 
two cell lines, i.e., Bomac cells with and without per-
sisting BVDV, were made available and both cell lines 
showed no macroscopic differences. This has allowed the 
investigation of the potential synergism of BVDV and M. 
bovis as suggested in previous studies [31, 52, 53]. Fur-
thermore, considering the switch in central Europe from 
subclinical to clinical mastitis in the mid-2000s [45], two 
different M. bovis strains were selected for the study. The 
two strains belong to two different clonal complexes with 
one strain being isolated before 2007 and one after 2007 
in Switzerland when cases of severe mastitis started to 
be observed. The aim of this study was to correlate cell 
infection with cell viability, cytotoxicity and induction of 
apoptosis with the two strains of M. bovis belonging to 
two different CC and to investigate a potential influence 
of BVDV.
Our findings show that both M. bovis strains were able 
to enter in and grow in co-culture with Bomac cells either 
in single infection with M. bovis or in co-infection with 
BVDV (Figure 3). The rate of uptake of the two bacterial 
strains was similar for Bomac cells infected with BVDV 
or free of BVDV (Figure  3). Additionally, no statistical 
significant differences were observed in the number of 
mycoplasmas of both strains recovered 54  h post-infec-
tion in both cell lines after gentamicin treatment. Major 
differences between Bomac cells infected with BVDV and 
free of BVDV were not observed with respect to myco-
plasmal uptake and number of recovered M. bovis dur-
ing co-cultures for 54  h. It has to be noted that growth 
of M. bovis strain JF4278 was observed in spent MEM-
Earle medium possibly due to substances secreted by 
Bomac cells or due to intracellular components Bomac 
cells released into the medium upon death of Bomac 
cells. These findings suggest that the Bomac cells can be 
used as a model to investigate the molecular mechanisms 
involved in cell uptake of M. bovis and co-culture even 
if infected with BVDV. Additional parameters could be 
tested in the future to investigate other aspects of co-
infection between M. bovis and BVDV or even test mul-
tiple co-infections. However, it has to be emphasized that 
this is an in  vitro model lacking the activity of comple-
ment or other serum components that could modify the 
interaction between macrophages and M. bovis.
Concerning the assays evaluating Bomac cells 
responses, cell viability was not drastically changed after 
infection with M. bovis (Figure  4). A slight increase in 
cytotoxicity was measured after infection of Bomac cells 
free of BVDV with the strain JF4278 (Figure  5). This 
observation cannot be confirmed in the case of Bomac 
cells infected with BVDV because of the high variability 
of cytotoxicity measured in Bomac cells infected with 
BVDV. However, staurosporine induced apoptosis in 
both cell lines with the cytotoxicity signal being lower 
after infection with both strains of M. bovis in Bomac 
cells free of BVDV. Cell infection with M. bovis strain 
JF4278 in Bomac cells with and without BVDV slightly 
induced apoptosis. This trend was also noticed after 
induction of apoptosis with staurosporine. Previous stud-
ies investigating apoptosis in monocytes/macrophages 
after infection with M. bovis showed a delayed apoptosis 
induced by this mycoplasmal species [21, 22, 37]. Delayed 
apoptosis could not be observed with the test used in this 
study. However, vanden Bush and Rosenbusch showed 
induction of apoptosis in lymphocytes after infection 
with M. bovis [23] but the cell response can be different 
between macrophages and lymphocytes. Interestingly, 
Zhang et  al. recently showed induction of apoptosis in 
Bomac cells after incubation with a recombinant nucle-
ase of M. bovis (MBOV_RS2825) associated with cyto-
toxicity [54].
In summary, no differences were observed at the level 
of cell uptake and growth in co-culture between the two 
strains of M. bovis and between cells infected or not with 
BVDV. Cell uptake and co-culture of M. bovis with both 
Bomac cell types did not decrease cell viability when cells 
were untreated with staurosporine. However, a slight 
increased cytotoxicity was observed after infection of 
Bomac cells without BVDV with the strain JF4278. Addi-
tionally, a small increase in apoptosis was measured after 
infection of both cell lines with M. bovis strain JF4278. 
These results show that the BVDV present in the infected 
cell line does not substantially change the parameters 
tested in this study. However, the BVDV status of in vitro 
models should be tested for research purposes especially 
considering that a wide variety of cells are known to be 
contaminated with BVDV [55–57]. Although cell cul-
tures are generally tested to detect mycoplasma contami-
nations, examinations for BVDV are not widespread [58]. 
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Although the curing of BVDV is time-consuming and 
might not always be successful, the information about its 
presence or absence is essential and researchers should at 
least test for it and be aware whether the virus is present 
or not because the virus might still influence other cel-
lular parameters. Since many cells from cattle and other 
ruminants are infected with BVDV, this study aimed to 
measure different bovine cell responses between BVDV-
free and BVDV-infected cells after M. bovis infection. 
This aspect is relevant not only for the interpretation of 
experimental data, but also because this virus was sug-
gested to interact with M. bovis during natural infection.
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